ANI PHARMACEUTICALS INC - Common Stock (ANIP)
CUSIP: 00182C103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,278,088
- Total 13F shares
- 19,725,780
- Share change
- -311,184
- Total reported value
- $1,287,090,849
- Put/Call ratio
- 64%
- Price per share
- $65.25
- Number of holders
- 229
- Value change
- -$20,870,018
- Number of buys
- 115
- Number of sells
- 99
Quarterly Holders Quick Answers
What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00182C103:
Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
12%
|
2,646,630
|
$177,191,878 | — | 31 Mar 2025 | |
| MERIDIAN VENTURE PARTNERS II LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,819,259
|
$102,678,978 | — | 16 Aug 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.3%
|
1,181,471
|
$79,099,484 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
3.8%
|
818,341
|
$57,136,569 | -$19,037,261 | 31 Mar 2025 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
3.3%
|
735,590
|
$49,247,751 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.2%
|
723,329
|
$48,426,877 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
714,570
|
$47,840,462 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
3.1%
|
700,000
|
$46,865,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.8%
|
631,786
|
$42,298,073 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.8%
|
631,561
|
$42,283,133 | — | 31 Mar 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
2.6%
|
571,638
|
$38,271,164 | — | 31 Mar 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
528,276
|
$35,368,078 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2%
|
448,835
|
$30,050,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
437,453
|
$29,287,536 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
429,626
|
$28,769,498 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
422,750
|
$28,303,112 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.9%
|
419,099
|
$28,058,678 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.8%
|
390,832
|
$26,166,203 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
317,500
|
$21,256,625 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
286,776
|
$19,199,653 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
264,390
|
$17,700,911 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
238,377
|
$15,959,340 | — | 31 Mar 2025 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
1.1%
|
237,027
|
$15,869,000 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1%
|
229,701
|
$15,378,482 | — | 31 Mar 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1%
|
224,684
|
$15,042,594 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.99%
|
219,502
|
$14,695,659 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.98%
|
218,086
|
$14,600,858 | — | 31 Mar 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.97%
|
217,176
|
$14,539,933 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.97%
|
216,862
|
$14,518,911 | — | 31 Mar 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.97%
|
215,721
|
$14,442,522 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.94%
|
210,390
|
$14,086,000 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.22%
|
48,000
|
$13,648,925 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.9%
|
199,567
|
$13,361,011 | — | 31 Mar 2025 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.89%
|
197,473
|
$13,220,817 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.87%
|
193,888
|
$12,981,000 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.83%
|
185,475
|
$12,417,608 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.75%
|
166,448
|
$11,143,694 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.71%
|
157,798
|
$10,564,577 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
140,549
|
$9,409,756 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.63%
|
139,280
|
$9,324,796 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.54%
|
119,262
|
$7,984,610 | — | 31 Mar 2025 | |
| James G. Marken |
3/4/5
|
SVP OPS & PROD DEV |
—
class O/S missing
|
117,829
|
$7,977,023 | — | 07 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.51%
|
114,618
|
$7,673,675 | — | 31 Mar 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
108,600
|
$7,270,770 | — | 31 Mar 2025 | |
| Lisanti Capital Growth, LLC |
13F
|
Company |
0.47%
|
105,425
|
$7,058,204 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.47%
|
105,000
|
$7,029,750 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.45%
|
100,164
|
$6,706,110 | — | 31 Mar 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.39%
|
87,298
|
$5,844,601 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.34%
|
74,992
|
$5,020,713 | — | 31 Mar 2025 | |
| MARATHON CAPITAL MANAGEMENT |
13F
|
Company |
0.31%
|
69,195
|
$4,632,605 | — | 31 Mar 2025 |
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q2 2025
As of 30 Jun 2025,
ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,725,780 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Global Alpha Capital Management Ltd., STATE STREET CORP, Deep Track Capital, LP, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, Ranger Investment Management, L.P., and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
This page lists
229
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
226
Q2 2025 holders
229
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.